The value of DNA analysis for antigens of the Kell and Kx blood group systems

Transfusion

Volumn 47, Issue SUPPL. 1, 2007, Pages

  Lee, Soohee ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; DNA;

AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KX SYSTEM; BLOOD GROUP SYSTEM; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CONFERENCE PAPER; DNA MICROARRAY; ERYTHROCYTE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNOASSAY; IMMUNOPHENOTYPING; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANEMIA, NEONATAL; ANTIGENS; DNA; HEMATOLOGIC TESTS; HUMANS; INFANT, NEWBORN; KELL BLOOD-GROUP SYSTEM; MODELS, BIOLOGICAL; MODELS, MOLECULAR;

EID: 34250675175     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01308.x     Document Type: Conference Paper

References (64)

1. Khamlichi S, Bailly P, Blanchard D, et al. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem 1995 228 : 931 4.
2. Russo D, Redman C, Lee S. Association of XK and Kell blood group proteins. J Biol Chem 1998 273 : 13950 6.
3. Lee S, Zambas ED, Marsh WL, et al. Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci U S A 1991 88 : 6353 7.
4. Lee S, Lin M, Mele A, et al. Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 1999 94 : 1440 50.
5. Ho M, Chelly J, Carter N, et al. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994 77 : 869 80.
6. Lee S, Russo D, Redman CM. The Kell blood group system: Kell and XK membrane proteins. Semin Hematol 2000 37 : 113 21.
7. Carbonnet F, Hattab C, Collec E, et al. Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides. Br J Haematol 1997 96 : 857 63.
8. Lee S, Zambas E, Green ED, et al. Organization of the gene encoding the human Kell blood group protein. Blood 1995 85 : 1364 70.
9. Lee S, Debnath AK, Redman CM. Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11. Blood 2003 102 : 3028 34.
10. Lee S, Debnath AK, Wu X, et al. Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM. Transfusion 2006 46 : 1323 7.
11. Lee S. Molecular basis of Kell blood group phenotypes. Vox Sang 1997 73 : 1 11.
12. Lee S, Wu X, Reid M, et al. Molecular basis of the Kell (K1) phenotype. Blood 1995 85 : 912 16.
13. Lee S, Wu X, Son S, et al. Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles. Transfusion 1996 36 : 490 4.
14. Yazdanbakhsh K, Lee S, Yu Q, et al. Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999 94 : 310 18.
15. Lee S, Wu X, Reid M, et al. Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system. Transfusion 1995 35 : 822 5.
16. Sha Q, Redman CM, Lee S. Endothelin-3-converting enzyme activity of the KEL1 and KEL6 phenotypes of the Kell blood group system. J Biol Chem 2006 281 : 7180 2.
17. Lee S, Russo D, Redman C. Functional and structural aspects of the Kell blood group system. Transfus Med Rev 2000 14 : 93 103.
18. Lee S, Russo DC, Reiner AP, et al. Molecular defects underlying the Kell null phenotype. J Biol Chem 2001 276 : 27281 9.
19. Wester ES, Storry JR, Schneider K, et al. Genetic basis of the K(0) phenotype in the Swedish population. Transfusion 2005 45 : 545 9.
20. Yu LC, Twu YC, Chang CY, et al. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens. J Biol Chem 2001 276 : 10247 52.
21. Lee S, Russo DC, Reid ME, et al. Mutations that diminish expression of Kell surface protein and lead to the Kmod RBC phenotype. Transfusion 2003 43 : 1121 5.
22. Marsh WL, Jensen LJ, Oyen R, et al. Anti K-13 and the K:-13 phenotype: a blood-group variant related to the Kell System. Vox Sang 1974 26 : 34 40.
23. Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986 154 : 85 90.
24. Bowman JM, Pollock JM, Manning FA, et al. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992 79 : 239 44.
25. Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998 338 : 798 803.
26. Pu JJ, Redman CM, Visser JW, et al. Onset of expression of the components of the Kell blood group complex. Transfusion 2005 45 : 969 74.
27. Southcott MJ, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999 93 : 4425 35.
28. Daniels G, Hadley A, Green CA. Causes of fetal anemia in hemolytic disease due to anti-K. Transfusion 2003 43 : 115 16.
29. Avent ND, Martin PG. Kell typing by allele-specific PCR (ASP). Br J Haematol 1996 93 : 728 30.
30. Hessner MJ, McFarland JG, Endean DJ. Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers. Transfusion 1996 36 : 495 9.
31. Lee S, Bennett PR, Overton T, et al. Prenatal diagnosis of Kell blood group genotypes: Kel1 and KEL2. Am J Obstet Gynecol 1996 175 : 455 9.
32. Van der Schoot CE, Tax GH, Rijnders RJ, et al. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003 17 : 31 44.
33. Walker RH, Danek A, Uttner I, et al. McLeod phenotype without the McLeod syndrome. Transfusion 2007 47 : 299 305.
34. Brown J, Dry KL, Edgar AJ, et al. Analysis of three deletion breakpoints in Xp21.1 and the further localization of RP3. Genomics 1996 37 : 200 10.
35. Bertelson CJ, Pogo AO, Chaudhuri A, et al. Localization of the McLeod locus (XK) within Xp21 by deletion analysis. Am J Hum Genet 1988 42 : 703 11.
36. Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001 50 : 755 64.
37. de Saint-Basile G, Bohler MC, Fischer A, et al. Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype. Hum Genet 1988 80 : 85 9.
38. El NW, Colin Y, Collec E, et al. Analysis of deletions in three McLeod patients: exclusion of the XS locus from the Xp21.1-Xp21.2 region. Eur J Immunogenet 2000 27 : 29 33.
39. Francke U, Ochs HD, de Martinville B, et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet 1985 37 : 250 67.
40. Frey D, Machler M, Seger R, et al. Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus. Blood 1988 71 : 252 5.
41. Ho MF, Monaco AP, Blonden LA, et al. Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21. Am J Hum Genet 1992 50 : 317 30.
42. Peng J, Redman CM, Wu X, et al. Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases. Gene 2007 DOI: 10.1016/j.gene.2006.11.023.
43. Ueyama H, Kumamoto T, Nagao S, et al. A novel mutation of the McLeod syndrome gene in a Japanese family. J Neurol Sci 2000 176 : 151 4.
44. Jung HH, Hergersberg M, Vogt M, et al. McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement. Transfusion 2003 43 : 928 38.
45. Supple SG, Iland HJ, Barnett MH, et al. A spontaneous novel XK gene mutation in a patient with McLeod syndrome. Br J Haematol 2001 115 : 369 72.
46. Russo DC, Oyen R, Powell VI, et al. First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease. Transfusion 2000 40 : 1371 5.
47. Daniels GL, Weinauer F, Stone C, et al. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells. Blood 1996 88 : 4045 50.
48. Russo DC, Lee S, Reid ME, et al. Point mutations causing the McLeod phenotype. Transfusion 2002 42 : 287 93.
49. Poole J, Warke N, Hustinx H, et al. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen. Transfusion 2006 46 : 1879 85.
50. Lee S, Naime DS, Reid ME, et al. Molecular basis for the high-incidence antigens of the Kell blood group system. Transfusion 1997 37 : 1117 22.
51. Lee S, Naime D, Reid M, et al. The KEL24 and KEL14 alleles of the Kell blood group system. Transfusion 1997 37 : 1035 8.
52. Lee S, Reid ME, Redman CM. Point mutations in KEL exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the Kell blood group system. Vox Sang 2001 81 : 259 63.
53. Grey D, Poole J, Martin P, et al. Hemolytic disease of the newborn caused by a new Kell antigen (Abstract). Transfus Med 2003 13 (Suppl 1 30.
54. Uchikawa M, Onodera K, Ogasawara K, et al. Molecular basis for a novel low-frequency antigen in the Kell blood group system, KYO (Abstract). Vox Sang 2006 91 (Suppl 3 136.
55. Koda Y, Soejima M, Tsuneoka M, et al. Heterozygosity for two novel null alleles of the KEL gene causes the Kell-null phenotype in a Japanese woman. Br J Haematol 2002 117 : 220 5.
56. Wester S, Ligthart C, Steffensen MT, et al. Typing discrepancies reveal two new KELnull mutations in the introns flanking exon 8 (Abstract). Vox Sang 2006 91 (Suppl 3 138.
57. Doescher A, Wagner F, Petershofen EK. K Null phenotype caused by premature stop codon in exon 14 of KEL gene: a case report (Abstract). Vox Sang 2006 91 (Suppl 3 109.
58. Zeman A, Daniels G, Tilley L, et al. McLeod syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK gene. Psychiatr Genet 2005 15 : 291 3.
59. Ho MF, Chalmer RM, Davis MB, et al. A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann Neurol 1996 39 : 672 5.
60. Hanaoka N, Yoshida K, Nakamura A, et al. A novel frameshift mutation in the McLeod syndrome gene in a Japanese family. J Neurol Sci 1999 165 : 6 9.
61. Wendel S, Fontão-Wendel R, Levi JE, et al. A McLeod phenotype detected by random screening for K:-4 [Kp(b-)] blood donors in Brazil. Transfusion 2004 44 : 1579 87.
62. Singleton BK, Green CA, Renaud S, et al. McLeod syndrome resulting from a novel XK mutation. Br J Haematol 2003 122 : 682 5.
63. Dotti MT, Battisti C, Malandrini A, et al. McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene. Mov Disord 2000 15 : 1282 4.
64. Jung HH, Hergersberg M, Kneifel S, et al. McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann Neurol 2001 49 : 384 92.